Literature DB >> 9581958

Susceptibility to atrial fibrillation: a study in an ovine model of pacing-induced early heart failure.

J M Power1, G A Beacom, C A Alferness, J Raman, M Wijffels, S J Farish, L M Burrell, A M Tonkin.   

Abstract

INTRODUCTION: The development of susceptibility to atrial fibrillation (AF) is a common consequence of many forms of cardiovascular disease, especially heart failure. In this study we used a sheep model of pacing-induced stable early heart failure to describe, quantify, and relate the level of susceptibility to AF to changes in structural and electrophysiologic parameters. METHODS AND
RESULTS: Epicardial electrodes were implanted on the atria and right ventricles of nine sheep. The AF threshold, atrial vulnerability period, atrial effective refractory period (ERP), and interatrial conduction time were examined during control and over a 6-week period of ventricular pacing at 190 beats/min. Left atrial (LA) area and left ventricular (LV) fractional shortening were monitored using echocardiography. There were significant increases in LA susceptibility to AF (P < 0.0003), LA area (P < 0.0002), and LA ERP400 (P < 0.0002). Rate of increase in LA area was related positively to AF susceptibility (P = 0.02) and inversely to LA ERP400 (P = 0.002). LV fractional shortening decreased to approximately 50% of control value (P < 0.00001). No changes were observed in right atrial electrophysiology.
CONCLUSION: In this study, susceptibility (the ability of an extrastimulus to induce AF) was rigorously measured within a predetermined format. Significant relationships were found to exist between susceptibility, certain of the observed changes in atrial electrophysiology and structure.

Entities:  

Mesh:

Year:  1998        PMID: 9581958     DOI: 10.1111/j.1540-8167.1998.tb00930.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  10 in total

1.  Pacing induced sustained atrial fibrillation in a pony.

Authors:  G van Loon; R Tavernier; M Duytschaever; W Fonteyne; P Deprez; L Jordaens
Journal:  Can J Vet Res       Date:  2000-10       Impact factor: 1.310

2.  Efficacy of the Acorn Cardiac Support Device in animals with heart failure secondary to high rate pacing.

Authors:  John M Power; Jai Raman; Melissa J Byrne; Clif A Alferness
Journal:  Heart Fail Rev       Date:  2005-06       Impact factor: 4.214

Review 3.  Atrial Septal Defect and Atrial Fibrillation: The Known and Unknown.

Authors:  George E Blake; Dhanunjaya Lakkireddy
Journal:  J Atr Fibrillation       Date:  2008-09-16

Review 4.  Atrial Remodeling And Atrial Fibrillation: Mechanistic Interactions And Clinical Implications.

Authors:  Bandar Al Ghamdi; Walid Hassan
Journal:  J Atr Fibrillation       Date:  2009-06-01

Review 5.  Is extensive atrial fibrosis in the setting of heart failure associated with a reduced atrial fibrillation burden?

Authors:  Alexander Burashnikov; Charles Antzelevitch
Journal:  Pacing Clin Electrophysiol       Date:  2018-09-09       Impact factor: 1.976

Review 6.  Atrial fibrillation: mechanisms, therapeutics, and future directions.

Authors:  Jason Pellman; Farah Sheikh
Journal:  Compr Physiol       Date:  2015-04       Impact factor: 9.090

Review 7.  Mechanisms of termination and prevention of atrial fibrillation by drug therapy.

Authors:  A J Workman; G L Smith; A C Rankin
Journal:  Pharmacol Ther       Date:  2011-02-18       Impact factor: 12.310

Review 8.  Gene therapy for atrial fibrillation - How close to clinical implementation?

Authors:  Amar Trivedi; Jacob Hoffman; Rishi Arora
Journal:  Int J Cardiol       Date:  2019-08-07       Impact factor: 4.164

9.  Recent clinical and experimental advances in atrial fibrillation.

Authors:  Shigeru Miyagawa; Taichi Sakaguchi; Hiroyuki Nishi; Yasushi Yoshikawa; Satsuki Fukushima; Shunsuke Saito; Yoshiki Sawa
Journal:  ISRN Cardiol       Date:  2011-08-01

Review 10.  Preclinical models of congestive heart failure, advantages, and limitations for application in clinical practice.

Authors:  Marta Saura; Jose Luis Zamorano; Carlos Zaragoza
Journal:  Front Physiol       Date:  2022-08-04       Impact factor: 4.755

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.